Cardinal Health Appoints New Medical Segment CEO

Cardinal Health announced that Stephen Mason, president of the company’s Cardinal Health at-Home Solutions business, has been promoted to CEO of Cardinal Health’s Medical segment. Mason will succeed Jon Giacomin, who will be departing the company in mid-August to assume a CEO position at a privately-held company.
 
Mason is a highly accomplished 20-year veteran of Cardinal Health and has successfully led several businesses within both Cardinal Health’s Medical and Pharmaceutical segments.
 
Since 2016, Mason has overseen Cardinal Health at-Home Solutions, a component of the Medical segment that has delivered strong and consistent growth. Prior to that, he led Cardinal Health’s Kinray pharmaceutical distribution business. Mason also has deep experience leading sales, sales operations, and sourcing teams within the company’s Pharmaceutical Distribution business, including the Consumer Health, Sales Administration, Retail Independent Sales and Retail National Accounts teams.  
 
Mike Kaufmann, CEO of Cardinal Health, commented, “We are pleased to name Steve Mason as the new CEO of our Medical segment. He is a proven leader who has consistently generated positive results in every business he has led within the company. With Steve at the helm, we look forward to building on the steady progress underway in the Medical segment as we continue to execute on our strategy to generate improved performance and long-term growth.
 
“We want to thank Jon Giacomin for his many contributions to Cardinal Health over the years and wish him well,” concluded Kaufmann.
 
Mason added, “I am excited to take on responsibility for our Medical segment and to work with our talented team of leaders to continue to position our Medical businesses to best serve our customers and the healthcare community while, very importantly, meeting our long-term growth and profitability objectives. I am confident in the plans we have in place to deliver on our strategy.”
 
Separately, Cardinal Health affirmed that it expects to meet at least the midpoint of its non-GAAP EPS guidance range for fiscal year 2019, which was reported in its May 9, 2019 earnings release. As announced, the company will report its financial results for its fiscal fourth quarter and year-end, as well as its outlook for fiscal 2020, on August 8, 2019, prior to market open.